ir.resourcesconnection.com
Investor Relations - RGPThe Investor Relations website contains information about RGP business for stockholders, potential investors, and financial analysts.
http://ir.resourcesconnection.com/
The Investor Relations website contains information about RGP business for stockholders, potential investors, and financial analysts.
http://ir.resourcesconnection.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
PAGES IN
THIS WEBSITE
16
SSL
EXTERNAL LINKS
0
SITE IP
23.213.123.49
LOAD TIME
0 sec
SCORE
6.2
Investor Relations - RGP | ir.resourcesconnection.com Reviews
https://ir.resourcesconnection.com
The Investor Relations website contains information about RGP business for stockholders, potential investors, and financial analysts.
ir.resourcesconnection.com
Annual Report - RGP
http://ir.resourcesconnection.com/annuals-proxies.cfm
Corporate Governance - RGP
http://ir.resourcesconnection.com/corporate-governance.cfm
Code of Business Conduct and Ethics. Corporate Governance and Nominating Committee Charter. Our Company is committed to the policy that all employees have an obligation to report problems or concerns involving ethical or compliance violations or complaints regarding accounting, internal accounting controls or auditing matters. All calls to our HOTLINE can be made anonymously and without fear of retribution.
Financial Highlights - RGP
http://ir.resourcesconnection.com/financials.cfm
Investor Relations - RGP
http://ir.resourcesconnection.com/index.cfm
RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 70 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 14, 2016. Resources Global Professionals Q416 Earnings Conference Call. June 7, 2016. Baird's 2016 Global Consumer, Technology and Services Conference.
Quarterly Information - RGP
http://ir.resourcesconnection.com/results.cfm
TOTAL PAGES IN THIS WEBSITE
16
Renesola - Investors - Investor Home
Stock Quote and Chart. Founded in 2005, and listed on the New York Stock Exchange in 2008, ReneSola (NYSE:SOL) is an international leading brand and technology provider of green energy products. Leveraging its global presence, expansive OEM and sales network, Renesola is well positioned to provide its highest quality green energy products and on-time services for EPC, installers, and green energy projects around the world. For more information, please visit www.renesola.com. Tel: 86-21-62809180 ext 105.
Investor Relations :: Rennova Health, Inc. (RNVA)
Rennova Health Provides Outlook for 2017. January 5, 2017. Rennova Health Provides Outlook for 2017. Jan 5, 2017. Ended Sep 30, 2016. Sign Up for Email Alerts. Be the first to receive breaking news. Jersey City, NJ 07310. 10320 N 56th Street. Tampa, FL 33617.
Renren - INVESTOR RELATIONS - Overview
Started from university campuses in 2005, we now possess a nation-wide penetration with users across all demographics, particularly college students and young white-collar professionals. Our social networking platform serves as the foundation of our business and we aim to build a mobile-centric eco-system that embodies our user needs. As a leader in mobile social networking, we are dedicated in continuing to transform ourselves into a full-fledged mobile technology Company. 160; 0.02. This calendar conta...
RepliCel | Using Cells for Healing
Tel: 604-248-8730 Toll Free: 1-800-248-5255. 4th largest cosmetics company worldwide. Ongoing tendon repair trial. Results expected in 2016. Ongoing skin rejuvenation trial. Results expected in 2016. Our stock trades on the OTCQB. And on the TSX Venture Exchange. TSXV: RP OTCQB: REPCF. Learn more about investing in RepliCel below. SIGN-UP HERE FOR FUTURE UPDATES. HERE’S WHAT INDUSTRY EXPERTS ARE SAYING:. 8220;When I can get potential blue-sky regenerative technologies like. Michael May, Centre for Commer...
Repros Therapeutics Inc. - Investor Relations
Board of Directors and Management. Events, Presentations and Webcasts. Repros in the News. Events, Presentations and Webcasts. Repros in the News. 12:34 PM ET on Jan 12, 2017. Delayed at least 20 minutes. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Repros Therapeutics Inc.'s financial performance into perspective. Dec 19, 2016. Dec 12, 2016. View all releases ». 2408 Timberloch Place, B-7.
Investor Relations - RGP
RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 68 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 16, 2015. Resources Global Professionals Q415 Earnings Conference Call. Resources Global Professionals Announces Quarterly Dividend Payment Date and New Stock Buyback Authorization. To Enhance Resident Safety.
Investor Relations - RGP
RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 68 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 16, 2015. Resources Global Professionals Q415 Earnings Conference Call. Resources Global Professionals Announces Quarterly Dividend Payment Date and New Stock Buyback Authorization. To Enhance Resident Safety.
Retrophin, Inc. - Investor Relations
Retrophin, Inc. (NASDAQ: RTRX) is a publicly-traded, San Diego-based biopharmaceutical company focused on the discovery, acquisition, development and commercialization of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently limited patient options. The Company is currently focused on several catastrophic diseases affecting children, including Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), and...
Reunert Limited Integrated Annual report 2013 | Home
2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. CHIEF EXECUTIVE OFFICER'S REPORT.
Investor Relations | REVA Medical
Skip to main navigation. REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications. The Company’s lead product, the Fantom bioresorbable scaffold, received European CE Mark on April 3, 2017 for the treatment of coronary artery disease. ASX RVA.AX (CDI). Mar 30, 2018 12:26 AM EDT. 10 CDIs equivalent to one share of common stock. March 27, 2018. REVA Announces First Implant of Fantom Encore in Switzerland.
INVESTOR RELATIONS | Rex Energy Corporation
Skip to main navigation. Owner and Leasing Relations. Feb 06, 2018. Rex Energy Announces Fourth Quarter and Full Year 2017 Production and Estimated Price Realizations and Provides Operational Update. Jan 23, 2018. Rex Energy Appoints New Chief Financial Officer. 7:18 PM EDT on Mar 29, 2018. Mar 14, 2018. Rex Energy Announces Sale of Non-Operated Oil and Gas Interests in Westmoreland, Centre and Clearfield Counties. Feb 06, 2018. Jan 23, 2018. Rex Energy Appoints New Chief Financial Officer.
SOCIAL ENGAGEMENT